Your browser doesn't support javascript.
loading
Liver-Selective Imidazolopyrazine Mitochondrial Uncoupler SHD865 Reverses Adiposity and Glucose Intolerance in Mice.
Beretta, Martina; Dai, Yumin; Olzomer, Ellen M; Vancuylenburg, Calum S; Santiago-Rivera, José A; Philp, Ashleigh M; Hargett, Stefan R; Li, Keyong; Shah, Divya P; Chen, Sing-Young; Alexopoulos, Stephanie J; Li, Catherine; Harris, Thurl E; Lee, Brendan; Wathier, Michel; Cermak, Jennifer M; Tucker, Simon P; Turner, Nigel; Bayliss, Douglas A; Philp, Andrew; Byrne, Frances L; Santos, Webster L; Hoehn, Kyle L.
Afiliação
  • Beretta M; School of Biotechnology and Biomolecular Sciences, University of New South Wales, Kensington, New South Wales, Australia.
  • Dai Y; Department of Chemistry and Virginia Tech Center for Drug Discovery, Virginia Tech, Blacksburg, VA.
  • Olzomer EM; School of Biotechnology and Biomolecular Sciences, University of New South Wales, Kensington, New South Wales, Australia.
  • Vancuylenburg CS; School of Biotechnology and Biomolecular Sciences, University of New South Wales, Kensington, New South Wales, Australia.
  • Santiago-Rivera JA; Department of Chemistry and Virginia Tech Center for Drug Discovery, Virginia Tech, Blacksburg, VA.
  • Philp AM; St Vincent's Clinical School, UNSW Medicine, University of New South Wales, Sydney, New South Wales, Australia.
  • Hargett SR; Department of Pharmacology, University of Virginia, Charlottesville, VA.
  • Li K; Department of Pharmacology, University of Virginia, Charlottesville, VA.
  • Shah DP; School of Biotechnology and Biomolecular Sciences, University of New South Wales, Kensington, New South Wales, Australia.
  • Chen SY; School of Biotechnology and Biomolecular Sciences, University of New South Wales, Kensington, New South Wales, Australia.
  • Alexopoulos SJ; School of Biotechnology and Biomolecular Sciences, University of New South Wales, Kensington, New South Wales, Australia.
  • Li C; School of Biotechnology and Biomolecular Sciences, University of New South Wales, Kensington, New South Wales, Australia.
  • Harris TE; Department of Pharmacology, University of Virginia, Charlottesville, VA.
  • Lee B; Biological Resources Imaging Laboratory, University of New South Wales, Sydney, New South Wales, Australia.
  • Wathier M; Life Biosciences, Boston, MA.
  • Cermak JM; Life Biosciences, Boston, MA.
  • Tucker SP; Life Biosciences, Boston, MA.
  • Turner N; Firebrick Pharma, Melbourne, Victoria, Australia.
  • Bayliss DA; Cellular Bioenergetics Laboratory, Victor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia.
  • Philp A; Department of Pharmacology, University of Virginia, Charlottesville, VA.
  • Byrne FL; Centre for Healthy Ageing, Centenary Institute, Camperdown, New South Wales, Australia.
  • Santos WL; School of Sport, Exercise and Rehabilitation Sciences, University of Technology Sydney, Sydney, New South Wales, Australia.
  • Hoehn KL; Charles Perkins Centre, The University of Sydney, Camperdown, New South Wales, Australia.
Diabetes ; 73(3): 374-384, 2024 Mar 01.
Article em En | MEDLINE | ID: mdl-37870907
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Intolerância à Glucose / Diabetes Mellitus Tipo 2 Limite: Animals / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Intolerância à Glucose / Diabetes Mellitus Tipo 2 Limite: Animals / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article